Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">NV1FGF: Phase III start</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

SAN will begin in the fourth quarter a double-blind, placebo-controlled Phase III trial. ......

Cardiovascular

Ophthalmic

NV1FGF: Phase III start

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

East-West Healthcare Reception

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.